Lundberg, Lindsay <br/><br/>
Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses.  [electronic resource] 

 -  Antiviral research  09 2018 
 - 57-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1872-9096 
<br/><br/><label>Standard No.: </label>10.1016/j.antiviral.2018.07.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alphavirus--drug effects<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antiviral Agents--pharmacology<br/>Cell Line<br/>Drug Evaluation, Preclinical--methods<br/>Drug Repositioning<br/>Genes, Reporter<br/>High-Throughput Screening Assays<br/>Luciferases--analysis<br/>Luminescent Measurements<br/>Reverse Genetics<br/>Sorafenib--pharmacology<br/>Virus Replication--drug effects